Zeng Z, Fu J, Cibulskis C...Wistuba II, Liu XS, Wu C Cross-site concordance evaluation of tumor DNA and RNA sequencing platforms for the CIMAC-CIDC network., , Clin Cancer Res, Dec 16, 2020 ➔

Briest F, Koziolek EJ, Albrecht J...Brenner W, Baum RP, Grabowski P Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? – A preclinical assessment in vitro and in vivo., , Neoplasia, Nov 26, 2020 ➔

Segar JM, Pandey R, Farr KJ, Nagle R, LeBeau L, Gonzalez VJ, Chalasani P Clinicopathological and Molecular Characteristics of Pleomorphic Invasive Lobular Carcinoma., , Int J Breast Cancer, Nov 23, 2020 ➔

Pudelko L, Jaehrling F, Reusch C...Rosell R, Schumacher KM, Karachaliou N SHP2 Inhibition Influences Therapeutic Response to Tepotinib in Tumors with MET Alterations., , iScience, Nov 21, 2020 ➔

Busse A, Mochmann LH, Spenke C, Arsenic R, Briest, F, Jöhrens K, Lammert H, Sipos B, Kühl AA, Wirtz R, Pavel M, Hummel M, Kaemmerer D, Baum RP, Grabowski P Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment., , Cancers , Nov 20, 2020 ➔

Bilusic M, Girardi D, Zhou Y...Flieder D, Gray P, Plimack E Molecular Profiling of Exceptional Responders to Cancer Therapy., , Oncologist, Nov 20, 2020 ➔

Farrow NE, Holl EK, Jung J...Tyler DS, Nair SK, Beasley GM Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma., , Ann Surg Oncol, Nov 18, 2020 ➔

Lee YS, Lee WS, Kim CW...Kim WR, Chon HJ, Kim C Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer., , J Immunother Cancer, Nov 17, 2020 ➔

Liang CW, Yang CY, Flavin R, Fletcher JA, Lu TP, Lai IR, Li YI, Chang YL, Lee JC Loss of SFRP1 expression is a key progression event in gastrointestinal stromal tumor pathogenesis., , Hum Pathol, Nov 11, 2020 ➔

Tan GF, Goh S, Lim AH...Chuan-Young Ng C, Teh BT, Chan JY Bizarre giant cells in human angiosarcoma exhibit chemoresistance and confer poor survival outcomes., , Cancer Sci, Nov 09, 2020 ➔

Selvanesan BC, Meena K, Beck A, Meheus L, Lara O, Rooman I, Gravekamp C Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice., , J Immunother Cancer, Nov 06, 2020 ➔

Qin Y, Bollin K, de Macedo MP...Lazar AJ, Hwu P, Patel SP Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy., , J Immunother Cancer, Nov 02, 2020 ➔

Kim K, Sohn YJ, Lee R, Yoo HJ, Kang JY, Choi N, Na D, Yeon JH Cancer-Associated Fibroblasts Differentiated by Exosomes Isolated from Cancer Cells Promote Cancer Cell Invasion., , Int J Mol Sci, Nov 01, 2020 ➔

Yabuno A, Matsushita H, Hamano T...Fujiwara K, Kakimi K, Hasegawa K Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinoma., , Sci Rep, Oct 29, 2020 ➔

Groeneveldt C, Kinderman P, van den Wollenberg DJM, van den Oever RL, Middelburg J, Mustafa DAM, Hoeben RC, van der Burg SH, van Hall T, van Montfoort N Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy., , J Immunother Cancer, Oct 20, 2020 ➔